What is the 10X Genomics Inc (TXG) price today?

The price of 10X Genomics Inc (TXG) today is $23.27. This value reflects the latest market rate available on Pluang. Check the asset page for additional details such as 24-hour change, market trends, and trading volume.

What are the trading hours of US Stocks?

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.

Do I get a dividend from investing in US Stocks?

Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.

What is the fee for each transaction?

Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Trade on Pluang

One platform for all markets

Download

Investment

Features

Fees Safety

Academy

Pluang+

Home/Explore/US Market Price/Stocks/TXG

Buy & Sell 10X Genomics Inc (TXG) – 10X Genomics Inc Price Today

Overview Financials Technicals Analysis Corp Action About

24H

YTD

Aura AI Summary

TXG trades at $23.05, showing slight daily gains amid bullish technical signals and positive earnings momentum with recent beats. The company maintains strong gross margins near 69% but continues to report net losses, though improving from -41.2% to -6.8% margin in 2025. Recent analyst upgrades and institutional buying activity reflect growing confidence in the consumables-driven growth story and AI-driven spatial biology applications.

The stock presents a turnaround opportunity as profitability improves, but faces execution risks amid high valuation multiples. With analyst consensus leaning neutral and price target below current levels, near-term upside appears limited despite positive business developments. Key risks include sustained profitability challenges and competitive pressures in the genomics instrumentation market.

Read full analysis

Key Stats

Market Cap
$2.94B
Sector
Health
3M Drawdown
-28.03%
Enterprise Value
$2.50B
Dividend Yield
-
Typical Hold Time
95 days

$23.27

52W Low: $7.51

17 Apr 2025

52W High: $23.27

10 Apr 2026

10X Genomics Inc (TXG) is currently valued at a market capitalization of $2.94B, with an enterprise value of $2.50B. Over the past 52 weeks, 10X Genomics Inc has traded between a low of $7.51 and a high of $23.27, highlighting its annual price range. Over the past three months, 10X Genomics Inc has recorded a drawdown of -28.03%, reflecting recent price volatility. 10X Genomics Inc offers a dividend yield of -. On average, investors hold 10X Genomics Inc for approximately 95 days, indicating typical investor behavior on the platform.

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

Technical Indicators

Overall Summary

Bearish (8)Neutral (1)Bullish (18)

News

Globe Newswire6 mon ago

Single-cell Analysis Market to Reach USD 12.29 Billion by 2032, Driven by Expanding Oncology Research and Advanced Genomics – SNS Insider

Globe Newswire10 mon ago

Molecular Diagnostics for Cancer Market Research 2025: Advances in Personalized Medicine and Liquid Biopsies Reshape Industry Landscape

Globe Newswire1 year ago

[Latest] Global Single Cell Multiomics Market Size/Share Worth USD 18.90 Billion by 2033 at a 19.58% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Globe Newswire1 year ago

Spatial Proteomics Market Report and Competitive Landscape 2025-2030, with 10X Genomics, Bruker, Fluidigm, Akoya Biosciences, PerkinElmer, Biotechne, S2 Genomics, Seven Bridges Genomics & More

Globe Newswire1 year ago

RNA Transcriptome Profiling Tests Market Expands at 14.5% CAGR, Surpassing US$ 37 Billion by 2034 | Fact.MR Report

People also bought

US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

Market Cap
$2.94B
Sector
Health
3M Drawdown
-28.03%
Enterprise Value
$2.50B
Dividend Yield
-
Typical Hold Time
95 days

$23.27

52W Low: $7.51

17 Apr 2025

52W High: $23.27

10 Apr 2026

Let’s invest in this asset by signing up or download!

Buy & Sell 10X Genomics Inc (TXG) – 10X Genomics Inc Price Today

Aura AI Summary

Key Stats

About 10X Genomics Inc

People also bought

Key Stats

Invest

Features

Fees

Learn

Investment Clubs (Coming Soon)

Support

iOS App Store

Google Play Store